These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28328761)

  • 21. [Pharmacoeconomic analysis of the efficacy of natalizumab in relapsing-remitting multiple sclerosis].
    Sabanov AV; Luneva AV; Matveev NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(5):65-9. PubMed ID: 24988963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
    Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E;
    J Clin Neurosci; 2014 Nov; 21(11):1847-56. PubMed ID: 24986155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.
    Freedman MS
    Eur J Neurol; 2014 Mar; 21(3):377-87, e18-20. PubMed ID: 24237582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates.
    Dubey D; Kieseier BC; Hartung HP; Hemmer B; Miller-Little WA; Stuve O
    Expert Rev Clin Immunol; 2015 Jan; 11(1):93-108. PubMed ID: 25495182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
    Bergvall N; Petrilla AA; Karkare SU; Lahoz R; Agashivala N; Pradhan A; Capkun G; Makin C; McGuiness CB; Korn JR
    J Med Econ; 2014 Oct; 17(10):696-707. PubMed ID: 25019581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alemtuzumab treatment of multiple sclerosis.
    Coles AJ
    Semin Neurol; 2013 Feb; 33(1):66-73. PubMed ID: 23709214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm.
    Cree BAC; Mares J; Hartung HP
    Curr Opin Neurol; 2019 Jun; 32(3):365-377. PubMed ID: 30985372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Monoclonal antibodies for the treatment of multiple sclerosis].
    Sánchez-Seco VG; Casanova Peño I; Arroyo González R
    Med Clin (Barc); 2014 Dec; 143 Suppl 3():30-4. PubMed ID: 25732947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of children and adolescents with multiple sclerosis.
    Banwell B
    Expert Rev Neurother; 2005 May; 5(3):391-401. PubMed ID: 15938672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidrug Antibodies: B Cell Immunity Against Therapy.
    Fogdell-Hahn A
    Scand J Immunol; 2015 Sep; 82(3):184-90. PubMed ID: 26098690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New management algorithms in multiple sclerosis.
    Sorensen PS
    Curr Opin Neurol; 2014 Jun; 27(3):246-59. PubMed ID: 24759080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of anti-natalizumab antibodies in multiple sclerosis patients.
    Lundkvist M; Engdahl E; Holmén C; Movérare R; Olsson T; Hillert J; Fogdell-Hahn A
    Mult Scler; 2013 May; 19(6):757-64. PubMed ID: 23045379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.
    Meca-Lallana JE; Fernández-Prada M; García Vázquez E; Moreno Guillén S; Otero Romero S; Rus Hidalgo M; Villar Guimerans LM; Eichau Madueño S; Fernández Fernández Ó; Izquierdo Ayuso G; Álvarez Cermeño JC; Arnal García C; Arroyo González R; Brieva Ruiz L; Calles Hernández C; García Merino A; González Plata M; Hernández Pérez MÁ; Moral Torres E; Olascoaga Urtaza J; Oliva-Nacarino P; Oreja-Guevara C; Ortiz Castillo R; Oterino A; Prieto González JM; Ramió-Torrentá L; Rodríguez-Antigüedad A; Saiz A; Tintoré M; Montalbán Gairin X
    Neurologia (Engl Ed); 2022 Oct; 37(8):615-630. PubMed ID: 36195374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?
    Fragoso YD; Arruda NM; Arruda WO; Brooks JB; Correa EC; Damasceno A; Damasceno CA; Ferreira ML; Giacomo MC; Gomes S; Gonçalves MV; Grzesiuk AK; Kaimen-Maciel DR; Lopes J; Machado SC; Oliveira CL; Stella CR
    Expert Rev Neurother; 2014 Feb; 14(2):127-30. PubMed ID: 24417188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alemtuzumab for multiple sclerosis.
    Lancet; 2012 Nov; 380(9856):1792. PubMed ID: 23122653
    [No Abstract]   [Full Text] [Related]  

  • 37. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Disease-modifying treatments in multiple sclerosis].
    Confavreux C; Bouhour F; Vukusic S
    Rev Prat; 1999 Nov; 49(17):1882-9. PubMed ID: 10598505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current treatment of multiple sclerosis].
    Gout O; Bensa C; Assouad R
    Rev Med Interne; 2010 Aug; 31(8):575-80. PubMed ID: 20579785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and future disease-modifying therapies in multiple sclerosis.
    Lim SY; Constantinescu CS
    Int J Clin Pract; 2010 Apr; 64(5):637-50. PubMed ID: 20456216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.